Folgen
Maria Stepanova
Maria Stepanova
Research Investigator, Inova Health System
Bestätigte E-Mail-Adresse bei cldq.org
Titel
Zitiert von
Zitiert von
Jahr
Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008
ZM Younossi, M Stepanova, M Afendy, Y Fang, Y Younossi, H Mir, ...
Clinical gastroenterology and hepatology 9 (6), 524-530. e1, 2011
12732011
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
ZM Younossi, D Blissett, R Blissett, L Henry, M Stepanova, Y Younossi, ...
Hepatology 64 (5), 1577-1586, 2016
9732016
Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver‐related mortality
ZM Younossi, M Stepanova, N Rafiq, H Makhlouf, Z Younoszai, ...
Hepatology 53 (6), 1874-1882, 2011
6392011
Adipokines and cytokines in non‐alcoholic fatty liver disease
MH Jarrar, A Baranova, R Collantes, B Ranard, M Stepanova, C Bennett, ...
Alimentary pharmacology & therapeutics 27 (5), 412-421, 2008
5872008
Nonalcoholic fatty liver disease in lean individuals in the United States
ZM Younossi, M Stepanova, F Negro, S Hallaji, Y Younossi, B Lam, ...
Medicine 91 (6), 319-327, 2012
5252012
Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates
Z Younossi, M Stepanova, JP Ong, IM Jacobson, E Bugianesi, A Duseja, ...
Clinical gastroenterology and hepatology 17 (4), 748-755. e3, 2019
4922019
Extrahepatic manifestations of hepatitis C: a meta-analysis of prevalence, quality of life, and economic burden
Z Younossi, H Park, L Henry, A Adeyemi, M Stepanova
Gastroenterology 150 (7), 1599-1608, 2016
3992016
Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population
M Stepanova, ZM Younossi
Clinical Gastroenterology and Hepatology 10 (6), 646-650, 2012
3772012
Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease
N Hossain, A Afendy, M Stepanova, F Nader, M Srishord, N Rafiq, ...
Clinical Gastroenterology and Hepatology 7 (11), 1224-1229. e2, 2009
3412009
A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH)
ZM Younossi, M Jarrar, C Nugent, M Randhawa, M Afendy, M Stepanova, ...
Obesity surgery 18, 1430-1437, 2008
3372008
Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study
M Stepanova, N Rafiq, ZM Younossi
Gut 59 (10), 1410-1415, 2010
3172010
Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD)
M Stepanova, N Rafiq, H Makhlouf, R Agrawal, I Kaur, Z Younoszai, ...
Digestive diseases and sciences 58, 3017-3023, 2013
2702013
Epidemiology of chronic liver diseases in the USA in the past three decades
ZM Younossi, M Stepanova, Y Younossi, P Golabi, A Mishra, N Rafiq, ...
Gut 69 (3), 564-568, 2020
2572020
In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009
M Stepanova, A Mishra, C Venkatesan, ZM Younossi
Clinical gastroenterology and hepatology 10 (9), 1034-1041. e1, 2012
2532012
Non‐alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population‐based study
L Gerber, M Otgonsuren, A Mishra, C Escheik, A Birerdinc, M Stepanova, ...
Alimentary pharmacology & therapeutics 36 (8), 772-781, 2012
2052012
Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States
ZM Younossi, M Stepanova, J Ong, G Trimble, S AlQahtani, I Younossi, ...
Clinical Gastroenterology and Hepatology 19 (3), 580-589. e5, 2021
1922021
Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir
ZM Younossi, M Stepanova, N Afdhal, KV Kowdley, S Zeuzem, L Henry, ...
Journal of hepatology 63 (2), 337-345, 2015
1812015
A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis
ZM Younossi, S Page, N Rafiq, A Birerdinc, M Stepanova, N Hossain, ...
Obesity surgery 21, 431-439, 2011
1812011
Associations of chronic hepatitis C with metabolic and cardiac outcomes
ZM Younossi, M Stepanova, F Nader, Z Younossi, E Elsheikh
Alimentary pharmacology & therapeutics 37 (6), 647-652, 2013
1772013
Predictors of health‐related quality of life in patients with chronic liver disease
A Afendy, JB Kallman, M Stepanova, Z Younoszai, RD Aquino, G Bianchi, ...
Alimentary pharmacology & therapeutics 30 (5), 469-476, 2009
1762009
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20